Login / Signup

In silico Evaluation of NO-Sartans against SARS-CoV-2.

Negar OmidkhahFarzin HadizadehRazieh GhodsiPrashant KesharwaniAmirhossein Sahebkar
Published in: Current drug discovery technologies (2024)
evaluations are necessary for the drug development process.
Keyphrases
  • sars cov
  • molecular docking
  • respiratory syndrome coronavirus